Taro Pharmaceutical Industries

NYSE:TARO   2:51:58 PM EDT
37.95
-0.15 (-0.39%)
Earnings Announcements

Taro Reports Qtrly Diluted Earnings Per Share Of $0.73

Published: 05/26/2022 23:10 GMT
Taro Pharmaceutical Industries (TARO) - Taro Provides Results for the Year Ended March 31, 2022.
Q4 Sales $143.3 Million.
Qtrly Diluted Earnings per Share of $0.73.
Revenue is expected to be $149.88 Million
Adjusted EPS is expected to be $0.85

Next Quarter Revenue Guidance is expected to be $153.63 Million
Next Quarter EPS Guidance is expected to be $0.94

More details on our Analysts Page.